OBJECTIVE: Māori women in New Zealand have higher incidence of and mortality from cervical cancer than non-Māori women, however limited research has examined differences in treatment and survival between these groups. This study aims to determine if ethnic disparities in treatment and survival exist among a cohort of Māori and non-Māori women with cervical cancer. METHODS: A retrospective cohort study of 1911 women (344 Māori and 1567 non-Māori) identified from the New Zealand Cancer Register with cervical cancer (adenocarcinoma, adenosquamous or squamous cell carcinoma) between 1 January 1996 and 31 December 2006. RESULTS: Māori women with cervical cancer had a higher receipt of total hysterectomies, and similar receipt of radical hysterectomies and brachytherapy as primary treatment, compared to non-Māori women (age and stage adjusted). Over the cohort period, Māori women had poorer cancer specific survival than non-Māori women (mortality hazard ratio (HR) 2.07, 95% confidence interval (CI): 1.63-2.62). From 1996 to 2005, the survival for Māori improved significantly relative to non-Māori. CONCLUSION: Māori continue to have higher incidence and mortality than non-Māori from cervical cancer although disparities are improving. Survival disparities are also improving. Treatment (as measured) by ethnicity is similar. IMPLICATIONS: Primary prevention and early detection remain key interventions for addressing Māori needs and reducing inequalities in cervical cancer in New Zealand.
OBJECTIVE: Māori women in New Zealand have higher incidence of and mortality from cervical cancer than non-Māori women, however limited research has examined differences in treatment and survival between these groups. This study aims to determine if ethnic disparities in treatment and survival exist among a cohort of Māori and non-Māori women with cervical cancer. METHODS: A retrospective cohort study of 1911 women (344 Māori and 1567 non-Māori) identified from the New Zealand Cancer Register with cervical cancer (adenocarcinoma, adenosquamous or squamous cell carcinoma) between 1 January 1996 and 31 December 2006. RESULTS: Māori women with cervical cancer had a higher receipt of total hysterectomies, and similar receipt of radical hysterectomies and brachytherapy as primary treatment, compared to non-Māori women (age and stage adjusted). Over the cohort period, Māori women had poorer cancer specific survival than non-Māori women (mortality hazard ratio (HR) 2.07, 95% confidence interval (CI): 1.63-2.62). From 1996 to 2005, the survival for Māori improved significantly relative to non-Māori. CONCLUSION: Māori continue to have higher incidence and mortality than non-Māori from cervical cancer although disparities are improving. Survival disparities are also improving. Treatment (as measured) by ethnicity is similar. IMPLICATIONS: Primary prevention and early detection remain key interventions for addressing Māori needs and reducing inequalities in cervical cancer in New Zealand.
Authors: Marion Maar; Ann Burchell; Julian Little; Gina Ogilvie; Alberto Severini; Jinghao Mary Yang; Ingeborg Zehbe Journal: Womens Health Issues Date: 2013 Sep-Oct
Authors: Christina Sinding; Rachel Warren; Donna Fitzpatrick-Lewis; Jonathan Sussman Journal: Support Care Cancer Date: 2014-08-14 Impact factor: 3.603
Authors: Marion Maar; Pamela Wakewich; Brianne Wood; Alberto Severini; Julian Little; Ann N Burchell; Gina Ogilvie; Ingeborg Zehbe Journal: Health Care Women Int Date: 2014-11-24
Authors: Naomi Brewer; Barry Borman; Diana Sarfati; Mona Jeffreys; Steven T Fleming; Soo Cheng; Neil Pearce Journal: BMC Cancer Date: 2011-04-12 Impact factor: 4.430
Authors: Brianne Wood; Ann N Burchell; Nicholas Escott; Julian Little; Marion Maar; Gina Ogilvie; Alberto Severini; Lisa Bishop; Kyla Morrisseau; Ingeborg Zehbe Journal: Front Oncol Date: 2014-02-19 Impact factor: 6.244
Authors: Jordan Tewhaiti-Smith; Alex Semprini; Deborah Bush; Augustus Anderson; Allie Eathorne; Neil Johnson; Jane Girling; Michael East; Joy Marriott; Mike Armour Journal: Sci Rep Date: 2022-03-15 Impact factor: 4.379
Authors: Andrea M Teng; June Atkinson; George Disney; Nick Wilson; Diana Sarfati; Melissa McLeod; Tony Blakely Journal: BMC Cancer Date: 2016-09-26 Impact factor: 4.430